MultiPark is a translational programme ranging from experimental pre-clinical research to studies on the life situation of patients with #neurodegeneration.
Important Update from MultiPark!
We want to inform you that MultiPark will no longer be active at X. You can continue to follow our latest research, news, and updates on LinkedIn 👉 linkedin.com/company/multipa…
Thank you for your support, and we look forward to staying in touch!
The glymphatic system, specialized in clearing waste from the brain, is linked to various neurodegenerative diseases. However, the impact of heart failure on the glymphatic system's function remains poorly understood.
"In this study we identify the glymphatic system as a new mechanism contributing to the well-established link between cardiovascular pathologies and neurodegeneration" says Marios Kritsilis, lead author of the project.
Read more about their findings 👉 doi.org/10.1093/brain/awae41…
Since the derivation of hPSCs, technologies to control their differentiation and manufacturing have advanced immensely, enabling increasing numbers of clinical trials with #hPSC-derived products.
🔎 Learn more in this @CellStemCell review.
bit.ly/41ZMTp5
The glymphatic system, a specialized waste-clearing network in the brain, plays a role similar to the lymphatic system in the rest of the body. Changes in this crucial system have been linked to neurodegenerative diseases such as Parkinson's and Alzheimer's.
However, a known limitation of DTI arises when nerve fibers cross—an issue affecting about 90% of the brain's white matter. In their study, the researchers demonstrated how fiber crossing impacts DTI measurements of the perivascular space and the assessment of glymphatic flow.
This work highlights both the potential and the challenges of using DTI in glymphatic research, paving the way for improved techniques to study brain health.
Read more about their findings here 👉 doi.org/10.1093/braincomms/f…
Lead author: Charalampos Georgiopoulos
Biomarkers have transformed Alzheimer's disease diagnosis, and a similar breakthrough is needed for Parkinson's disease and related disorders, known as Parkinsonian syndromes (PS).
Recent research highlights corticotropin-releasing hormone (CRH) as a promising biomarker candidate for PS. @OskarHansson9 and collaborators investigated this link, read about their results here 👉 doi.org/10.1093/braincomms/f…
Lead authors: @atulkumar1301 and Bárbara Fernandes Gomes
The episode I've been most excited about is here. I had the honor to chat with Prof. Bart de Strooper, one of the most brilliant minds researching Alzheimer's today. What an absolute masterclass it was. Listen to it, you won't regret it. @MultiparkLopen.spotify.com/episode/0xb…
Genetic risk factors can vary between populations. The T369M variant in the GBA1 gene has been linked to an 80% increased risk of Parkinson's disease. However, recent findings suggest this association might not apply to the Swedish population.
Lead author: @BrolinKajsa
Link to article 👉 doi.org/10.1016/j.parkreldis…
Are you intrigued by genes and Parkinson's disease? Then tune in to Maria's MultiPark podcast episode to hear about her journey as a scientist and her research 🎧 open.spotify.com/episode/5E2…